Dr. Umesh Masharani, MD

Dr. Masharani practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Masharani's NPI, 1972571255, was assigned on March 10, 2006. Dr. Masharani graduated from University of London Faculty of Medicine in 1982. Dr. Masharani holds California license A49824.

Dr. Masharani's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Masharani's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Masharani is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Masharani to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Masharani practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Masharani's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Masharani is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Masharani is licensed in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, hypercalcemia, obesity, osteoporosis and overactive thyroid among the conditions Dr. Masharani treats.

CMS data shows 1,637 Medicare services from Dr. Masharani across 11 procedure codes in 2024, for 396 Medicare patients. Medicare paid $96,933 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 396 Medicare patients who saw Dr. Masharani in 2024. The largest group is 65 to 74, with 173 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Masharani's median patient age at 65, with 60% women.

In 2024, Dr. Masharani wrote 2,890 Medicare Part D claims for 334 patients. 49% of them were for generic drugs. CMS names the drug for 2,521 of them, across 52 drugs with 11 or more claims each, at $849,097 in total drug cost. In 2023, CMS named 2,363 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Masharani for performance year 2024, reported as part of a group. Dr. Masharani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Masharani as offering telehealth.

Dmand AI links 96 papers to Dr. Masharani, published from 2005 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Diabetes Mellitus, Type 1, Blood Glucose and Diabetes Mellitus, Type 2. Dr. Masharani has published most often in Diabetes Care. Dr. Masharani's most frequent co-authors are Lawrence I. Fisher, MD, Lynda A. Frassetto, MD and Edward C. Hsiao, MD, PhD.

Dmand AI links Dr. Masharani to 8 clinical trials. Conditions studied include Ossification, Heterotopic, Myositis Ossificans and Insulin Resistance. University of California, San Francisco sponsors the most, 5.

CMS Open Payments shows 12 general payments to Dr. Masharani from 4 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 79% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,422. It also lists 1 research payment totaling $4,375 in 2021.

Dmand AI lists 3 awards for Dr. Masharani, most recently Regional Top Doctor in 2014.

Dr. Masharani graduated from University of London Faculty of Medicine in 1982.

Dr. Masharani is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.